Experimental Factor Ontology (EFO) Information | |
Identifier | EFO_0009271 |
Description | The result of a measurement of circulating Epstein Barr virus nuclear antigen-1 antibodies used in the diagnosis of latent Epstein-Barr virus infection | Trait category |
Other measurement
|
Synonyms |
2 synonyms
|
Mapped term | PMID:29868224 |
Polygenic Score ID & Name | PGS Publication ID (PGP) | Reported Trait | Mapped Trait(s) (Ontology) | Number of Variants |
Ancestry distribution GWAS Dev Eval |
Scoring File (FTP Link) |
---|---|---|---|---|---|---|
PGS001036 (GBE_INI23004) |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Epstein Barr virus nuclear antigen 1 IgG seropositivity | Epstein Barr virus nuclear antigen-1 seropositivity | 38 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001036/ScoringFiles/PGS001036.txt.gz |
PGS Performance Metric ID (PPM) |
Evaluated Score |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|---|
PPM007938 | PGS001036 (GBE_INI23004) |
PSS005011| African Ancestry| 119 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: EBNA-1 antigen for Epstein-Barr Virus | — | — | R²: 0.08991 [0.07665, 0.10318] Incremental R2 (full-covars): 0.0329 PGS R2 (no covariates): 0.04656 [0.03656, 0.05656] |
age, sex, UKB array type, Genotype PCs | — |
PPM007939 | PGS001036 (GBE_INI23004) |
PSS005012| East Asian Ancestry| 41 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: EBNA-1 antigen for Epstein-Barr Virus | — | — | R²: 0.50637 [0.47308, 0.53966] Incremental R2 (full-covars): 0.00658 PGS R2 (no covariates): 0.00013 [-0.00095, 0.00122] |
age, sex, UKB array type, Genotype PCs | — |
PPM007940 | PGS001036 (GBE_INI23004) |
PSS005013| European Ancestry| 471 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: EBNA-1 antigen for Epstein-Barr Virus | — | — | R²: 0.11391 [0.10648, 0.12134] Incremental R2 (full-covars): 0.07089 PGS R2 (no covariates): 0.07891 [0.07248, 0.08533] |
age, sex, UKB array type, Genotype PCs | — |
PPM007941 | PGS001036 (GBE_INI23004) |
PSS005014| South Asian Ancestry| 164 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: EBNA-1 antigen for Epstein-Barr Virus | — | — | R²: 0.10651 [0.0936, 0.11942] Incremental R2 (full-covars): 0.02856 PGS R2 (no covariates): 0.02783 [0.02065, 0.03501] |
age, sex, UKB array type, Genotype PCs | — |
PPM007942 | PGS001036 (GBE_INI23004) |
PSS005015| European Ancestry| 1,275 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: EBNA-1 antigen for Epstein-Barr Virus | — | — | R²: 0.06244 [0.05891, 0.06598] Incremental R2 (full-covars): 0.06217 PGS R2 (no covariates): 0.07143 [0.06768, 0.07518] |
age, sex, UKB array type, Genotype PCs | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS005011 | — | — | 119 individuals | — | African unspecified | — | UKB | — |
PSS005012 | — | — | 41 individuals | — | East Asian | — | UKB | — |
PSS005013 | — | — | 471 individuals | — | European | non-white British ancestry | UKB | — |
PSS005014 | — | — | 164 individuals | — | South Asian | — | UKB | — |
PSS005015 | — | — | 1,275 individuals | — | European | white British ancestry | UKB | Testing cohort (heldout set) |